Skip to content

Endoscopic Radial versus Non-Radial Incision for Benign Esophageal Strictures: A Prospective, Multicenter Randomized Controlled Trial

Endoscopic Radial versus Non-Radial Incision for Benign Esophageal Strictures: A Prospective, Multicenter Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117877
Enrollment
Unknown
Registered
2026-01-29
Start date
2025-09-11
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal stricture

Interventions

observation group:Radioactive cutting
Intervention group:Non-radial incision

Sponsors

Cancer Hospital, Chongqing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age range: 18 to 80 years old. Physical condition should be able to tolerate endoscopic treatment and related examination and follow-up. Those diagnosed with benign esophageal stenosis based on medical history, clinical manifestations, gastroscopy, and imaging examinations (such as esophageal angiography, CT, etc.);patients with esophageal stenosis accompanied by symptoms such as dysphagia that affect their normal eating or quality of life;complete preoperative examinations, including biochemical tests, coagulation routine tests, and imaging examinations, etc., without any absolute contraindications for surgery;obtain written consent, voluntarily participate in this study and follow the requirements of the research protocol.

Exclusion criteria

Exclusion criteria: 1.Patients with esophageal stenosis or suspected malignant transformation of stenotic lesions caused by malignant tumors;patients with severe cardiac or pulmonary dysfunction, abnormal coagulation function, or other systemic diseases that prevent endoscopic procedures;patients with a history of esophageal surgery and severely altered anatomical structures that affect endoscopic incision operations or assessment;pregnant, lactating, or women planning to get pregnant during the study period; 5.patients with concurrent severe esophageal diseases (such as esophageal diverticulum, active esophageal variceal rupture bleeding, etc.) that may interfere with the interpretation of study results;severe mental disorders;patients who were participating in another clinical trial before randomization;patients who are unable to participate in follow-up.

Design outcomes

Primary

MeasureTime frame
The degree of improvement in esophageal stenosis 3 months after treatment (the re-stenosis rate 3 months after esophageal ESD);the alleviation of dysphagia, and the improvement in quality of life;

Secondary

MeasureTime frame
The incidence of complications;

Countries

China

Contacts

Public ContactChen Weiqing

Cancer Hospital, Chongqing University

chenweiqing506@yahoo.com+86 23 6531 1341

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026